Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- DTE +28.5%, ENLT +8%, ETOR +6.7%, FLR +6.6%, KNF +3.7%, WAY +3.5%, CEVA +3.4%, NESR +2.7%, LH +2.6%, SON +2.4%, KRYS +2%, RNW +1.9%, SSTK +1%
Other news:
- ZIM +35.2% (to be acquired by Hapag-Lloyd for $35 per share in $4.2 bln cash deal)
- CMPS +23.1% (announces successful achievement of the primary endpoint in the ongoing Phase 3 COMP006 trial)
- RYI +12.8% (Ryerson and Olympic Steel announce successful closing of merger)
- KW +9.7% (to be acquired in an all-cash transaction by Fairfax Financial Holdings (FRFHF) and KW Management Group for $10.90/share)
- NPO +5.2% (increases quarterly cash dividend 3.2% to $0.32/share from $0.31/share)
- BNC +4.4% (issues statement refuting YZi Labs' latest claims; Confirms BNC is fully compliant with Nasdaq rules for holding the annual meeting)
- LAD +3.2% (implements shift to align its IT and technology teams more closely)
- NWG +3.2% (launches £750 mln 2026 share buyback program)
- NKTR +3.2% (announces research collaboration with UCSF and Dr. Stephen Hauser for NKTR-0165, a Tumor Necrosis Factor Receptor 2 antibody, in multiple sclerosis)
- GSK +2.5% (receives EU approval for Exdensur in severe asthma and CRSwNP; launches £0.45 bln fourth tranche under £2 bln buyback program)
- ESLT +1.9% (secures $435 mln in multi-year international defense awards)
Analyst comments:
- LUV +2.1% (upgraded to Buy from Neutral at UBS)
- DLTR +1.8% (upgraded to Buy from Neutral at Rothschild & Co Redburn)
- ALB +1.2% (upgraded to Buy from Neutral at BofA Securities)
- ACN +0.9% (upgraded to Overweight from Equal Weight at Wells Fargo)
- UPST +0.7% (upgraded to Neutral from Sell at Compass Point)